AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Preos maker provides clinical update.(lead drug candidate for treating osteoporosis, NPS Pharmaceuticals )

Women's Health Weekly

| March 06, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 MAR 6 - (NewsRx.com & NewsRx.net) -- NPS Pharmaceuticals (NPSP) briefed the investment community on its most advanced clinical development programs during its recent presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference.

NPS reported that its lead drug candidate for treating osteoporosis, Preos, is progressing as planned through clinical trials, and that the company is preparing for its commercial launch.

The company emphasized that it now has enough finished Preos material to complete the phase III TOP ("Treatment of osteoporosis with PTH") study, which is on-track for conclusion in September 2003. The company also reported that since it instituted certain changes to the fill-and-finish process for Preos in June 2002, all batches have passed stability specifications.

More than 500 women have completed 18 months of dosing in the TOP study, and more than 75% of those patients have opted to receive Preos in the OLES ("Open Label Extension Study") trial, which allows for a total use of Preos of up to 24 ...

Related articles from newspapers, magazines, journals, and more
NPS Pharmaceuticals and Nycomed Announce US$90+ Million PREOS(R) Marketing...
Press release article from: PR Newswire April 21, 2004 700+ words
NPS Pharmaceuticals Inc. and Nycomed...osteoporosis drug PREOS(R) in Europe...and marketing of PREOS. Nycomed has agreed...daily injections of PREOS. About CalciChew...Europe. About NPS Pharmaceuticals NPS discovers...
NPS Pharmaceuticals Announces Positive Results of Three PREOS Trials at ASBMR;...
Press release article from: PR Newswire October 4, 2004 700+ words
...and a preclinical study with PREOS in rats to assess its potential...osteoporotic women, confirm that PREOS builds new bone with normal...Chief Medical Officer at NPS Pharmaceuticals, Inc. . "Based on these...settings, we believe that PREOS promises to become an integral...
NPS EYES NDA FILING FOR PREOS ON POSITIVE OSTEOPOROSIS TRIALS.(NPS...
Magazine article from: BIOWORLD Today Osborne, Randall March 31, 2004 700+ words
...supply of its osteoporosis drug Preos kept NPS Pharmaceuticals Inc. from forging ahead with...that we can use agents such as [Preos] in that population. I see...study, why an agent such as Preos cannot be used in severe cases...
Preos Data AT ACR Nicks NPS, But Anabolic Market 'Growing'.(American College of...
Magazine article from: BIOWORLD Today Huggett, Brady October 25, 2004 700+ words
...Huggett, Managing Editor NPS Pharmaceuticals Inc. on Thursday presented...from the TOP study of Preos, for vertebral fractures...of 100 micrograms of Preos or placebo, in addition...the administration of Preos resulted in a new or...
Positive Phase III results for NPS' Preos.(NPS Pharmaceuticals Inc.)(Brief...
Newspaper article from: Pharma Marketletter April 5, 2004 700+ words
USA-based NPS Pharmaceuticals has reported that a pivotal Phase III trial of its Preos, a recombinant human parathyroid...examine the potential of Preos in around 2,600 postmenopausal...Subjects received either 100mcg Preos or a placebo, in conjunction...
NPS update on Preos manufacturing.(NPS Pharmaceuticals Inc.)(Brief Article)
Magazine article from: Women's Health Weekly July 18, 2002 700+ words
...amp; NewsRx.net) -- NPS Pharmaceuticals, Inc., (NPSP) provided...manufacture of clinical supplies of Preos, its proprietary drug candidate...phase III clinical study of Preos in approximately 2600 women...that clinical supplies of Preos were not able to be produced...
NPS' PREOS "improves bone strength".(NPS Pharmaceuticals, parathyroid hormone...
Newspaper article from: Pharma Marketletter October 3, 2005 700+ words
NPS Pharmaceuticals has said that the results...demonstrate that treatment with PREOS (parathyroid hormone...New Drug Application for PREOS is currently under review...the European equivalent to PREOS, which will be marketed...
NPS Pharmaceuticals Provides Update of Progress With PREOS(TM) and Cinacalcet...
Press release article from: PR Newswire February 26, 2003 700+ words
NPS Pharmaceuticals, Inc. today provided an...of clinical progress with PREOS, a proprietary compound...prnh/20000218/NPSLOGO ) PREOS Update: Preliminary PaTH...benefits of using NPS's PREOS (intact, human parathyroid...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA